Isofol Medical AB (publ) announced that the EGM resolved, in accordance with the shareholders' (those requested the EGM to be convened) proposal, that the number of members of the board of directors shall be three without deputies. The EGM elected, in accordance with the shareholders' (those requested the EGM to be convened) proposal, Mats Franzén, Jonas Pedersén and Jan-Eric Österlund as new members of the board of directors. Mats Franzén was elected new chairman of the board of directors.

All elections for the period until the end of the next Annual General Meeting. The EGM further resolved to, in accordance with the shareholders' (those requested the EGM to be convened) proposal, that newly elected board members shall receive remuneration in accordance with the remuneration levels resolved by the Annual General Meeting 2022, proportionally to the term of office.